Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
22.30
+0.21 (0.95%)
At close: Dec 19, 2025, 4:00 PM EST
22.38
+0.08 (0.36%)
After-hours: Dec 19, 2025, 7:30 PM EST
Elanco Animal Health Revenue
Elanco Animal Health had revenue of $1.14B in the quarter ending September 30, 2025, with 10.39% growth. This brings the company's revenue in the last twelve months to $4.59B, up 3.08% year-over-year. In the year 2024, Elanco Animal Health had annual revenue of $4.44B with 0.50% growth.
Revenue (ttm)
$4.59B
Revenue Growth
+3.08%
P/S Ratio
2.41
Revenue / Employee
$485,820
Employees
9,450
Market Cap
11.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.44B | 22.00M | 0.50% |
| Dec 31, 2023 | 4.42B | 6.00M | 0.14% |
| Dec 31, 2022 | 4.41B | -353.00M | -7.41% |
| Dec 31, 2021 | 4.76B | 1.49B | 45.64% |
| Dec 31, 2020 | 3.27B | 200.00M | 6.51% |
| Dec 31, 2019 | 3.07B | 4.20M | 0.14% |
| Dec 31, 2018 | 3.07B | 177.80M | 6.15% |
| Dec 31, 2017 | 2.89B | -24.50M | -0.84% |
| Dec 31, 2016 | 2.91B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ELAN News
- 2 days ago - Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs - PRNewsWire
- 2 days ago - Jim Cramer Praises Elanco Animal Health: 'They've Turned That Company Around' - Benzinga
- 8 days ago - Elanco Animal Health Incorporated (ELAN) Analyst/Investor Day Transcript - Seeking Alpha
- 9 days ago - Animal Health Focused Elanco Details Pipeline Momentum, US Investments, Cost-Saving Plans - Benzinga
- 11 days ago - Elanco Investor Day Defines New Era as Sustainable Growth Company - PRNewsWire
- 16 days ago - Elanco Animal Health Incorporated (ELAN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - Elanco Animal Health Incorporated (ELAN) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 24 days ago - Elanco executive appointed as Neurizon's Board Observer - PRNewsWire